1887

Abstract

Summary

The sequences encoding the p24 core protein of human immunodeficiency virus type 1 were identified in a cDNA library made from infected CEM cells. The nucleotide sequence of the DNA coding for p24 was shown to be very similar but not identical to the sequences of lymphadenopathy virus and human T-cell leukaemia virus type IIIb. These sequences were expressed in at the amino terminus of -galactosidase and used to screen a panel of monoclonal antibodies raised against virus-expressed p24. Regions containing the epitopes of five of the monoclonal antibodies were located using a series of amino- and carboxy-terminal deletion mutants of the recombinant p24 protein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-11-2843
1989-11-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/11/JV0700112843.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-11-2843&mimeType=html&fmt=ahah

References

  1. Allan J. S., Coligan J. E., Lee T. H., Mclane M. F., Kanki P. J., Groopman J. R., Essex M. 1985; A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230:810–813
    [Google Scholar]
  2. Alizon M., Wain-Hobson S., Montagnier L., Sonigo P. 1986; Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell 46:63–74
    [Google Scholar]
  3. Allison J., Hall L., Macintyre I., Craig R. K. 1981; The construction and characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein. Biochemical Journal 199:725–731
    [Google Scholar]
  4. Androphy E. J., Hubbert N. J., Schiller T. J., Lowy D. R. 1987; Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO Journal 6:989–992
    [Google Scholar]
  5. Argos P. 1989; A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites. EMBO Journal 8:779–785
    [Google Scholar]
  6. Arya S. K., Guo C., Josephs S. F., Wong-Staal F. 1985; Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69–73
    [Google Scholar]
  7. Barre-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. 1983; Isolation of a T-lymphotropic retrovirus from a patient at risk from acquired immunodeficiency syndrome (AIDS). Science 220:868–870
    [Google Scholar]
  8. Benn S., Rutledge R., Folks T., Gold J., Baker L., Mccormick J., Feorino P., Piot P., Quinn T., Martin M. 1985; Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science 230:949–951
    [Google Scholar]
  9. Chirgwin J. M., Przybyla A. E., Macdonald R. J., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
    [Google Scholar]
  10. Essex M., Allan J., Kanki P., Mclane M. F., Malone G., Kitchen L., Lee T. H. 1985; Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Annals of Internal Medicine 103:700–703
    [Google Scholar]
  11. Feinberg A. P., Vogelstein B. 1983; A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry 132:6–13
    [Google Scholar]
  12. Feinberg A. P., Vogelstein B. 1984; A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum. Analytical Biochemistry 137:266–267
    [Google Scholar]
  13. Ferns R. B., Tedder R. S., Weiss R. A. 1987; Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. Journal of General Virology 68:1543–1551
    [Google Scholar]
  14. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B., White G., Foster P., Markham P. D. 1984; Frequent detection and isolation of cytopathic retrovirus (HTLV III) from patients with AIDS and at risk for AIDS. Science 224:500–503
    [Google Scholar]
  15. Gibson T. J. 1984 Studies on Epstein-Barr virus genome Ph.D. thesis, University of Cambridge;
    [Google Scholar]
  16. Hellings J. A., Meloen R. H., Schalken J. J. 1988; Epitope mapping of HIV GAG-prpteins by pepscan. Abstract 1162153IV International Conference on AIDSStockholmJune1216
    [Google Scholar]
  17. Huynh T. V., Young R. A., Davis R. W. 1985; Constructing and screening cDNA libraries in lambda gt10 and lambda gt11. In DNA Cloning 149–78 Glover D. M. Oxford: IRL Press;
    [Google Scholar]
  18. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature London; 227680–685
    [Google Scholar]
  19. Lee T. H., Coligan J. E., Allan J. S., Mclane M. F., Groopman J. E., Essex M. 1986; A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science 231:1546–1549
    [Google Scholar]
  20. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  21. Matlashewski G., Banks L., Wu-Liao J., Spence P., Pim D., Crawford L. 1986; The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies. Journal of General Virology 67:1909–1916
    [Google Scholar]
  22. Montagnier L. 1985; Lymphadenopathy-associated virus: from molecular biology to pathogenicity. Annals of Internal Medicine 103:689–693
    [Google Scholar]
  23. Montagnier L., Gruest J., Chamaret S., Dauguet C, Axler C, Guetard D., Nugeyre M. T., Barre-Sinoussi F., Chermann J. C., Brunet J. B., Klatzmann D., Gluckman J. C. 1984; Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science 225:63–66
    [Google Scholar]
  24. Pinching A., Weiss R. A. 1986; AIDS and the spectrum of HTLV-III/LAV infection. International Review of Experimental Pathology 28:647–666
    [Google Scholar]
  25. Ratner L., Haseltine W., Pararca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Pearson M. L., Lautenberger J. A., Papas T. S., Ghrayeb J., Chang N. T., Gallo R. C., Wong-staal F. 1985; Complete nucleotide sequence of the AIDS virus HTLV III. Nature London: 313277–283
    [Google Scholar]
  26. Sanchez-Pescador R., Power M. D., Barr P. J., Steimer K. S., Stempein M. M., Brown-Shimer S. L., Gee W. W., Renard A., Randolph A., Levy J. A., Dina D., Luciw P. A. 1985; Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484–492
    [Google Scholar]
  27. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of SciencesU.S.A 745463–5467
    [Google Scholar]
  28. Sodroski J. G., Rosen C. A., Wong-Staal F., Popovic M., Arya S., Gallo R. C., Haseltine W. A. 1985a; Transacting transcriptional activation of the long terminal repeat of human T cell leukemia virus type III (HTLV-III). Science 227:171–173
    [Google Scholar]
  29. Sodroski J. G., Goh W. C., Rosen C. A., Tartar A., Portetelle D., Burny A., Haseltine W. A. 1985b; Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science 231:1549–1553
    [Google Scholar]
  30. Spence R. P., Walker J., Jarvill W. M., Ferns R. B., Tedder R. S., Sattentau Q., Weber J., Parry N. R., Highfield P. E. 1989; The expression In Escherichia coli of sequences coding for the p18 protein of human immunodeficiency virus and the use of the recombinant protein in characterizing a panel of monoclonal antibodies against the viral p18 protein. Journal of General Virology 70:2853–2863
    [Google Scholar]
  31. Tabor S., Richardson C. C. 1987; DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proceedings of the National Academy of SciencesU.S.A 844767–4771
    [Google Scholar]
  32. Towbin H., Gordon J. 1984; Immunoblotting and dot immunobinding – current status and outlook. Journal of Immunological Methods 72:313–340
    [Google Scholar]
  33. Veronese F. D. M., Rahman R., Copeland T. D., Oroszlan S., Gallo R. C., Sarngadharan M. G. 1987; Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. AIDS Research and Human Retroviruses 3:253–264
    [Google Scholar]
  34. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. 1985; Nucleotide sequence of the AIDS virus, LAV. Cell 40:9–17
    [Google Scholar]
  35. Weiss R. A., Clapham P. R., Cheingsong-Popov R., Dalgleish A. G., Carne C., Weller I. V. D. 1985; Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS risk patients. Nature London: 31669–72
    [Google Scholar]
  36. Winther M. D., Allen G., Bomford R. H., Brown F. 1986; Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals. Journal of Immunology 136:1835–1840
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-11-2843
Loading
/content/journal/jgv/10.1099/0022-1317-70-11-2843
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error